157 related articles for article (PubMed ID: 2818016)
1. Relation between soluble interleukin 2 receptor and clinical findings in patients with systemic lupus erythematosus.
Tokano Y; Murashima A; Takasaki Y; Hashimoto H; Okumura K; Hirose S
Ann Rheum Dis; 1989 Oct; 48(10):803-9. PubMed ID: 2818016
[TBL] [Abstract][Full Text] [Related]
2. Increased soluble IL-2 receptor in serum of patients with systemic lupus erythematosus.
Sawada S; Hashimoto H; Iijma S; Tokano Y; Matsukawa Y; Takei M; Ishikawa H; Kang H; Tomura K; Mitamura K
Clin Rheumatol; 1993 Jun; 12(2):204-9. PubMed ID: 8358979
[TBL] [Abstract][Full Text] [Related]
3. The relationship between soluble interleukin 2 receptor levels and antidouble stranded DNA antibody levels in patients with systemic lupus erythematosus.
Ward MM; Dooley MA; Christenson VD; Pisetsky DS
J Rheumatol; 1991 Feb; 18(2):235-40. PubMed ID: 2023217
[TBL] [Abstract][Full Text] [Related]
4. Soluble interleukin-2 receptor levels in lupus nephritis.
Laut J; Senitzer D; Petrucci R; Sablay LB; Barland P; Glicklich D
Clin Nephrol; 1992 Oct; 38(4):179-84. PubMed ID: 1424303
[TBL] [Abstract][Full Text] [Related]
5. Correlation of serum interleukin-8 and cell surface lysosome-associated membrane protein expression with clinical disease activity in systemic lupus erythematosus.
Holcombe RF; Baethge BA; Wolf RE; Betzing KW; Stewart RM; Hall VC; Fukuda M
Lupus; 1994 Apr; 3(2):97-102. PubMed ID: 7920621
[TBL] [Abstract][Full Text] [Related]
6. Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products.
Lim KL; Jones AC; Brown NS; Powell RJ
Ann Rheum Dis; 1993 Jun; 52(6):429-35. PubMed ID: 8323394
[TBL] [Abstract][Full Text] [Related]
7. [Soluble interleukin 2 receptor as activity parameter in serum of systemic and discoid lupus erythematosus].
Blum C; Zillikens D; Tony HP; Hartmann AA; Burg G
Hautarzt; 1993 May; 44(5):290-5. PubMed ID: 8320115
[TBL] [Abstract][Full Text] [Related]
8. Serum interleukin-2 receptor in systemic lupus erythematosus and rheumatoid arthritis.
Lee GL; Chen MY; Chuang CY; Chen CY
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 Feb; 21(1):16-22. PubMed ID: 3264781
[TBL] [Abstract][Full Text] [Related]
9. Changes in plasma levels of interleukin-2 receptor in relation to disease exacerbations and levels of anti-dsDNA and complement in systemic lupus erythematosus.
ter Borg EJ; Horst G; Limburg PC; Kallenberg CG
Clin Exp Immunol; 1990 Oct; 82(1):21-6. PubMed ID: 2208793
[TBL] [Abstract][Full Text] [Related]
10. Relationship of IL-2, IL-2R (CD25+), soluble IL-2R and IL-4 with disease activity in SLE patients.
Cuadrado MJ; Marubayashi M; Ortega C; Fernandez-Arcas N; Garcia-Cozar F; Pena J; Sanchez-Guijo P; Santamaria M
Lupus; 1993 Aug; 2(4):257-60. PubMed ID: 8268974
[TBL] [Abstract][Full Text] [Related]
11. Impaired urinary excretion of soluble IL-2 receptors in patients with systemic lupus erythematosus and rheumatoid arthritis.
Manoussakis MN; Germanidis GS; Drosos AA; Moutsopoulos HM
Lupus; 1992 Feb; 1(2):105-9. PubMed ID: 1301961
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of serum levels of soluble interleukin-2 receptor as an indicator of disease activity in systemic lupus erythematosus.
AirÅ P; Braga S; Prati E; Brugnoni D; Bettinzioli M; Gorla R; Cattaneo R
Clin Rheumatol; 1992 Mar; 11(1):97-100. PubMed ID: 1582127
[TBL] [Abstract][Full Text] [Related]
13. Soluble interleukin 2 receptor molecules in the serum of patients with autoimmune diseases.
Manoussakis MN; Papadopoulos GK; Drosos AA; Moutsopoulos HM
Clin Immunol Immunopathol; 1989 Mar; 50(3):321-32. PubMed ID: 2783895
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the prevalence and clinical associations of antibodies to human fibronectin in systemic lupus erythematosus.
Atta MS; Lim KL; Ala'deen DA; Powell RJ; Todd I
Ann Rheum Dis; 1995 Feb; 54(2):117-24. PubMed ID: 7702398
[TBL] [Abstract][Full Text] [Related]
15. Changes in levels of soluble T-cell activation markers, sIL-2R, sCD4 and sCD8, in relation to disease exacerbations in patients with systemic lupus erythematosus: a prospective study.
Spronk PE; ter Borg EJ; Huitema MG; Limburg PC; Kallenberg CG
Ann Rheum Dis; 1994 Apr; 53(4):235-9. PubMed ID: 8203951
[TBL] [Abstract][Full Text] [Related]
16. Soluble interleukin-2 receptors in systemic lupus erythematosus.
Wolf RE; Brelsford WG
Arthritis Rheum; 1988 Jun; 31(6):729-35. PubMed ID: 3132927
[TBL] [Abstract][Full Text] [Related]
17. [Serum soluble interleukin 2 receptor levels in patients with diffuse connective tissue diseases].
Sun HY; Liu WL; Xiu HZ
Zhonghua Nei Ke Za Zhi; 1993 Aug; 32(8):528-30. PubMed ID: 8269781
[TBL] [Abstract][Full Text] [Related]
18. Assay for the soluble interleukin-2 receptor by sandwich enzyme linked immunosorbent assay.
Takaishi M; Akiyama M; Hayashi T; Hirai Y; Murakami Y; Ueda R; Tatsugawa K; Yamakido M; Tsubokura T
Jpn J Med Sci Biol; 1990 Oct; 43(5):151-61. PubMed ID: 2093128
[TBL] [Abstract][Full Text] [Related]
19. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
Dejica D
Roum Arch Microbiol Immunol; 2001; 60(3):183-201. PubMed ID: 12165973
[TBL] [Abstract][Full Text] [Related]
20. Increased levels of intercellular adhesion molecule-1 in the serum of patients with systemic lupus erythematosus.
Sfikakis PP; Charalambopoulos D; Vayiopoulos G; Oglesby R; Sfikakis P; Tsokos GC
Clin Exp Rheumatol; 1994; 12(1):5-9. PubMed ID: 7909280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
